Alabama Oncology is proud to recognize Dr. John Piede for his recent participation as expert faculty in an Answers in CME panel discussion, Integrating ESR1m Testing and Novel Oral SERDs Into Multidisciplinary Workflows: Regional Guidance for HR+, HER2- Advanced Breast Cancer. Dr. Piede joined nationally recognized breast cancer experts to share a community oncology perspective on incorporating ESR1 mutation testing, emerging endocrine therapies, and personalized treatment strategies into real-world patient care. We are proud to see Alabama Oncology represented in important educational conversations that help advance the care of patients with advanced breast cancer.  Dr. Piede is President and Managing Partner of Alabama Oncology, and practices at the Alabama Oncology clinic located in the Bruno Cancer Center on the campus of St. Vincent’s Birmingham Hospital.

CME Activity Link: https://www.answersincme.com/XKE

Presented By:

Erika Hamilton, MD, FASCO

Komal Jhaveri, MD, FACP, FASCO

Eleonora Teplinsky, MD, FASCO

John Allen Piede, MD